SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Lagoda-backed holder files Schedule 13D after 7.4% VolitionRx stake

Fatima Dickey, via Lagoda Investment Management, disclosed a 7.4% stake in VolitionRx. The holder switched from a passive Schedule 13G to an active Schedule 13D filed September 4, 2026.

VNRX

Fatima Dickey, through Lagoda Investment Management, disclosed a 7.4% stake in VolitionRx Limited. The group changed its filing from a passive Schedule 13G to an active Schedule 13D on September 4, 2026. The filing says the move is aimed at influencing costs while supporting the company’s strategy. Investor Inte…

Related stories